（来源：中国政府采购报） 转自：中国政府采购报 新闻一线 湖北细化落实政采异常低价治理规定 本报讯 记者马金眈报道 湖北省财政厅近日印发《关于落实推动解决政府采购异常低价问题有关事宜的 通知》，从采购需求管理、异常低价审查程序、履约验收、示范文本等方面结合省内实际细化有关要 求，推动形成优质优价、良性竞争市场秩序。 通知要求，采购人应严格编制采购需求，合理设定最高限价，合理设置采购包。对于信息化建设、耗材 用量大的仪器设备等项目，可以引入全生命周期成本理念，要将运营维护升级、专用耗材、处置报废等 费用纳入报价评审因素，并在合同中明确相关责任。采购人应在采购文件中明确规定四类异常低价投标 （响应）审查启动情形，启动异常低价审查的数值标准可根据实际情况适当提高至不超过65%。评审委 员会启动审查后，应要求相关供应商在合理时间内提交成本测算等书面说明及必要的证明材料，参考同 类项目中标（成交）价格、类似产品市场价格水平、行业人工费用标准、国家有关部门指导行业协会发 布的行业平均成本等对报价合理性进行判断。采购人、代理机构应为评审委员会在评审现场及时获取相 关信息资料提供便利。审查启动原因、审查意见和结果应在评审报告 ...

□ 政府采购产品一旦价格远低于正常成本，很可能带来项目履约质量下降、采购市场秩序混乱、财政资 金使用效益降低等一系列负面影响。 在加强政府采购需求管理方面，通知规定，采购人应当根据实际工作需要，综合考虑同类项目中标（成 交）信息，以及市场供给和产业发展状况，材料、人工等市场价格，行业费用标准等市场调查情况，形 成科学、完整、清晰的采购需求，合理设定最高限价，为供应商竞争报价提供基础。采购人要综合考虑 技术、成本效益、促进竞争等因素，按照专业类型和专业领域，合理设置采购包。采购人应当重点加强 对信息化建设项目和耗材使用量大的复印、打印、实验、医疗等仪器设备采购项目的管理。 在强化政府采购异常低价审查方面，通知提出，采购文件应当明确启动异常低价投标（响应）审查的情 形包括：报价低于全部有效报价平均值50%、低于次低报价50%、低于最高限价45%。采购人可以结合 具体项目实际情况，提高上述启动异常低价投标（响应）审查的数值标准，但是最高不得超过65%。 "政府采购关系到财政资金的使用，物有所值最重要。政府采购的产品之所以价格低廉是因为批量生产 带来的规模效应，一旦价格远低于正常成本，很可能带来项目履约质量下降、采购 ...

Core Viewpoint - The Ministry of Finance has issued a notice to address the issue of abnormally low bids in government procurement, marking a significant shift from a focus on low prices to an emphasis on quality and effectiveness in the medical equipment market [4][7]. Group 1: Government Procurement Reforms - The new regulations aim to combat the persistent issue of low-price bidding in the medical equipment sector, which has been detrimental to product quality and patient safety [9][10]. - The notice introduces a closed-loop system focusing on "source control, process review, and post-responsibility," addressing previous challenges in identifying and managing low-price bids [10][12]. Group 2: Impact on Medical Equipment Market - The introduction of a full lifecycle cost concept in procurement will require consideration of ongoing maintenance and consumable costs, thereby preventing the common practice of low initial bids followed by high consumable prices [12][13]. - The new rules will enhance scrutiny of low-price bids, with specific criteria established to identify and reject bids that are excessively low compared to market averages [12][13]. Group 3: Industry Dynamics and Competition - The reforms are expected to shift the competitive landscape, pushing domestic companies to transition from a price-based strategy to one focused on value [14]. - Foreign brands may benefit from the new emphasis on quality and service, as their technological advantages can be better recognized under the new evaluation criteria [14][15]. Group 4: Innovation and Market Growth - The reduction of low-price competition is anticipated to lead to increased investment in research and development, fostering innovation within the industry [15]. - With a projected budget of 19.6 billion for medical equipment updates, the new policies are expected to direct funds towards high-quality products and services, enhancing the efficiency of public healthcare resource allocation [15].